Aisa Pharma, Inc., a clinical-stage biopharmaceutical company focused on therapies for systemic sclerosis, today announced results from its Phase 2 RECONNOITER trial of AISA-021 (cilnidipine), a novel ...

Aisa Pharma announces positive results from phase 2 RECONNOITER trial of cilnidipine in patients with systemic sclerosis-associated Raynaud's phenomenon: Boston Monday, March 9, 2 ...

Rocket Pharmaceuticals, Inc. ( RCKT) TD Cowen 46th Annual Health Care Conference March 2, 2026 11:10 AM EST ...

A growing body of neuroimaging research is pinpointing exactly how psychedelic drugs hijack the brain’s visual system to ...

Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the ...

Good morning, everybody. My name is Kyahn Williamson, SVP of Investor Relations and Corporate Communications at Telix. And we're very pleased to welcome you today to our investor call and webcast to ...

The Inflation Reduction Act (IRA) represents a transformative shift in US health care policy by enabling Medicare to negotiate drug prices for high-expenditure medicatio ...

Tools designed to verify and monitor physical AI systems offer value, but human oversight is needed to prevent accidents and unexpected behavior.

The best sleep headbands provide everything from guided meditations to advanced sleep tracking. Here are our favorites from Muse, Frenz and more.

Beet juice and whole beets both contain plant compounds that may help lower blood pressure, including nitrates, potassium, and an antioxidant called betalain.

IPF, a global Phase 2 trial evaluating PIPE-791 for the treatment of patients with idiopathic pulmonary fibrosis (IPF)- Topline data from the exploratory PIPE-791 Phase 1b trial in patients with ...

Is green tea or kombucha better for daily drinking? Discover why green tea may be a more worry-free choice, and how kombucha carries some risks when overconsumed.